Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali

Somda, Zana C; Meltzer, Martin I.; Perry, Helen; Messonnier, Nancy E.; Usman, Abdulmumini; Mebrahtu, Goitom; Sacko, M; K, Toure; Ki, Salimata Ouedraogo; Okorosobo, Tuoyo; Alemu, Wondimagegnehu; Sow, Idrissa

doi:10.1186/1478-7547-7-1

Cited by 36 publications

(56 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among the various institutions supporting iVPD surveillance, costs borne by INCIENSA were highest, including personnel, equipment, supplies, and other cost components. This finding is similar to results reported by other authors [7]. …”

Section: Discussionsupporting

confidence: 94%

“…To our knowledge, very few studies have included cost analyses of surveillance systems [5-7], and ours is the first study reporting the costing of an iVPD surveillance system. Although available surveillance system costing studies are not directly comparable to ours, personnel and laboratory costs also represent the major cost components in these studies [5-7].…”

Section: Discussionmentioning

confidence: 99%

“…Although available surveillance system costing studies are not directly comparable to ours, personnel and laboratory costs also represent the major cost components in these studies [5-7]. …”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica

Toscano

Vijayaraghavan

Salazar-Bolaños³

et al. 2013

Vaccine

View full text Add to dashboard Cite

Introduction Following World Health Organization recommendations set forth in the Global Framework for Immunization Monitoring and Surveillance, Costa Rica in 2009 became the first country to implement integrated vaccine-preventable disease (iVPD) surveillance, with support from the U.S. Centers for Disease Control and Prevention (CDC) and the Pan American Health Organization (PAHO). As surveillance for diseases prevented by new vaccines is integrated into existing surveillance systems, these systems could cost more than routine surveillance for VPDs targeted by the Expanded Program on Immunization. Objectives We estimate the costs associated with establishing and subsequently operating the iVPD surveillance system at a pilot site in Costa Rica. Methods We retrospectively collected data on costs incurred by the institutions supporting iVPD surveillance during the preparatory (January 2007 through August 2009) and implementation (September 2009 through August 2010) phases of the iVPD surveillance project in Costa Rica. These data were used to estimate costs for personnel, meetings, infrastructure, office equipment and supplies, transportation, and laboratory facilities. Costs incurred by each of the collaborating institutions were also estimated. Results During the preparatory phase, the estimated total cost was 128,000 U.S. dollars (US$), including 64% for personnel costs. The preparatory phase was supported by CDC and PAHO. The estimated cost for 1 year of implementation was US$ 420,000, including 58% for personnel costs, 28% for laboratory costs, and 14% for meeting, infrastructure, office, and transportation costs combined. The national reference laboratory and the PAHO Costa Rica office incurred 64% of total costs, and other local institutions supporting iVPD surveillance incurred the remaining 36%. Conclusions Countries planning to implement iVPD surveillance will require adequate investments in human resources, laboratories, data management, reporting, and investigation. Our findings will be valuable for decision makers and donors planning and implementing similar strategies in other countries.

show abstract

Section: Discussionsupporting

confidence: 94%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica

Toscano

Vijayaraghavan

Salazar-Bolaños³

et al. 2013

Vaccine

View full text Add to dashboard Cite

show abstract

“…[31][32][33][34][35] For HIV surveillance, one study reported on the funding per case of HIV in the U.S., based on health departments' reported expenditures. 27 These expenditures, or budgetary data, do not necessarily equal cost data collected through micro-costing techniques because budgetary data may include unrelated costs, such as those for research, or exclude relevant costs (e.g., when the program was partially funded by the agency from whose perspective the cost analysis was conducted), and the analysis accounted for all of the surveillance cases.…”

Section: Discussionmentioning

confidence: 99%

Estimating the Cost to U.S. Health Departments to Conduct HIV Surveillance

et al. 2014

View full text Add to dashboard Cite

Objectives. HIV case surveillance is a primary source of information for monitoring HIV burden in the United States and guiding the allocation of prevention and treatment funds. While the number of people living with HIV and the need for surveillance data have increased, little is known about the cost of surveillance. We estimated the economic cost to health departments of conducting high-quality HIV case surveillance.Methods. We collected primary data on the unit cost and quantity of resources used to operate the HIV case surveillance program in Michigan, where HIV burden (i.e., the number of HIV cases) is moderate to high (n514,864 cases). Based on Michigan's data, we projected the expected annual HIV surveillance cost for U.S., state, local, and territorial health departments. We based our cost projection on the variation in the number of new and established cases, areaspecific wages, and potential economies of scale.Results. We estimated the annual total HIV surveillance cost to the Michigan health department to be $1,286,524 ($87/case), the annual total cost of new cases to be $108,657 ($133/case), and the annual total cost of established cases to be $1,177,867 ($84/case). Our projected median annual HIV surveillance cost per health department ranged from $210,600 in low-HIV burden sites to $1,835,000 in high-HIV burden sites.Conclusions. Our analysis shows that a systematic approach to costing HIV surveillance at the health department level is feasible. For HIV surveillance, a substantial portion of total surveillance costs is attributable to maintaining established cases.

show abstract

“…Data collection is never free; moreover, due to privacy concerns, individuals are becoming aware of the value of their data and resistant to share it for free [9]. In the case of infectious diseases, performing the necessary medical exams and the subsequent data analysis on many suspected households or communities can be exorbitantly expensive, whereas the efficient allocation of resources can lead to enormous savings [29].…”

Section: Introductionmentioning

confidence: 99%

Back To The Source

Spinelli

Celis

Thiran

2017

Proceedings of the 26th International Conference on World Wide Web

View full text Add to dashboard Cite

Abstract.Source localization, the act of finding the originator of a disease or rumor in a network, has become an important problem in sociology and epidemiology. The localization is done using the infection state and time of infection of a few designated sensor nodes; however, maintaining sensors can be very costly in practice.We propose the first online approach to source localization: We deploy a priori only a small number of sensors (which reveal if they are reached by an infection) and then iteratively choose the best location to place a new sensor in order to localize the source. This approach allows for source localization with a very small number of sensors; moreover, the source can be found while the epidemic is still ongoing. Our method applies to a general network topology and performs well even with random transmission delays.

show abstract

Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali

Cited by 36 publications

References 17 publications

Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica

Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica

Estimating the Cost to U.S. Health Departments to Conduct HIV Surveillance

Back To The Source

Contact Info

Product

Resources

About